Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Masellis

Showing results (51-60 of 368) with videos related to

Pageof 37
Sort By:
Psychiatric Genetics|April 20, 2004
Polymorphisms in glutamate decarboxylase genes: analysis in schizophreniaVincenzo De Luca, Pierandrea Muglia, Mario Masellis, et al.
Current Pharmacogenomics and Personalized Medicine|January 28, 2012
Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 ReceptorMichel C F Shamy, Clement Zai, Vincenzo S Basile, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersFuqiang Gao, Joel Ramirez, Melissa F Holmes, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 23, 2020
Feasibility of unattended home sleep apnea testing in a cognitively impaired clinic populationDavid R Colelli, Sandra E Black, Mario Masellis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 5, 2022
Effects of white matter hyperintensities, neuropsychiatric symptoms, and cognition on activities of daily living: Differences between Alzheimer's disease and dementia with Lewy bodiesSaira Saeed Mirza, Usman Saeed, Joel Ramirez, et al.
Current Pharmacogenomics and Personalized Medicine|May 1, 2012
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 MedicineVural Ozdemir, Erik Fisher, Edward S Dove, et al.
Journal of Alzheimer'S Disease : JAD|May 16, 2022
Data-Driven Analyses of Longitudinal Hippocampal Imaging Trajectories: Discrimination and Biomarker Prediction of Change ClassesShannon M Drouin, G Peggy McFall, Olivier Potvin, et al.
Psychoneuroendocrinology|September 7, 2015
DRD2 and SLC6A3 moderate impact of maternal depressive symptoms on infant cortisolJaclyn A Ludmer, Robert Levitan, Andrea Gonzalez, et al.
Human Brain Mapping|June 1, 2017
Heritability of hippocampal subfield volumes using a twin and non-twin siblings designSejal Patel, Min Tae M Park, Gabriel A Devenyi, et al.
Translational Neurodegeneration|April 1, 2017
Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging conceptsUsman Saeed, Jordana Compagnone, Richard I Aviv, et al.
Pageof 37

Showing results (51-60 of 368) with videos related to

Sort By:
Pageof 37
Psychiatric Genetics|April 20, 2004
Polymorphisms in glutamate decarboxylase genes: analysis in schizophreniaVincenzo De Luca, Pierandrea Muglia, Mario Masellis, et al.
Current Pharmacogenomics and Personalized Medicine|January 28, 2012
Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 ReceptorMichel C F Shamy, Clement Zai, Vincenzo S Basile, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersFuqiang Gao, Joel Ramirez, Melissa F Holmes, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 23, 2020
Feasibility of unattended home sleep apnea testing in a cognitively impaired clinic populationDavid R Colelli, Sandra E Black, Mario Masellis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 5, 2022
Effects of white matter hyperintensities, neuropsychiatric symptoms, and cognition on activities of daily living: Differences between Alzheimer's disease and dementia with Lewy bodiesSaira Saeed Mirza, Usman Saeed, Joel Ramirez, et al.
Current Pharmacogenomics and Personalized Medicine|May 1, 2012
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 MedicineVural Ozdemir, Erik Fisher, Edward S Dove, et al.
Journal of Alzheimer'S Disease : JAD|May 16, 2022
Data-Driven Analyses of Longitudinal Hippocampal Imaging Trajectories: Discrimination and Biomarker Prediction of Change ClassesShannon M Drouin, G Peggy McFall, Olivier Potvin, et al.
Psychoneuroendocrinology|September 7, 2015
DRD2 and SLC6A3 moderate impact of maternal depressive symptoms on infant cortisolJaclyn A Ludmer, Robert Levitan, Andrea Gonzalez, et al.
Human Brain Mapping|June 1, 2017
Heritability of hippocampal subfield volumes using a twin and non-twin siblings designSejal Patel, Min Tae M Park, Gabriel A Devenyi, et al.
Translational Neurodegeneration|April 1, 2017
Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging conceptsUsman Saeed, Jordana Compagnone, Richard I Aviv, et al.
Pageof 37